Skip to Main Content

Paper Details

The multi-kinase inhibitor CG-806 exerts anti-cancer activity against acute myeloid leukemia by co-targeting FLT3, BTK, and Aurora kinases.
Res Sq
1
2023
AML, Aurora kinases, BTK, Bcl-2, CG-806, FLT3, FLT3-mutant, FLT3-mutant acute myeloid leukemias, Mcl-1, TKD, WT cells, acute myeloid leukemia, aurora kinases, cancer, leukemia, mutant cells, mutant leukemia, mutant leukemia cells, patients, tyrosine, tyrosine kinase domains, wild-type (WT) cells
Author NameAffiliation
Wei ZhangUniversity of Texas MD Anderson Cancer Center.
Wei ZhangUniversity of Texas MD Anderson Cancer Center.
Hongying Zhang
William G Rice
  • 1 - 4

Datasets

Release 1.2